Increased serotonin 2C receptor mRNA editing: A possible risk factor for suicide

Molecular Psychiatry

Volumn 13, Issue 11, 2008, Pages 1001-1010

  Dracheva, S ^a,b   Patel, N ^a   Woo, D A ^a   Marcus, S M ^a,b   Siever, L J ^a,b   Haroutunian, V ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

ADAR; Bipolar disorder; Prefrontal cortex; RNA editing; Schizophrenia; Suicide

Indexed keywords

MESSENGER RNA; SEROTONIN 2C RECEPTOR;

AGE; ALCOHOL CONSUMPTION; ARTICLE; BIPOLAR DISORDER; BRAIN; COMORBIDITY; DRUG USE; FEMALE; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RISK FACTOR; RNA EDITING; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; SEX; SUICIDAL BEHAVIOR; SUICIDE;

ADULT; BIPOLAR DISORDER; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; MODELS, MOLECULAR; PREFRONTAL CORTEX; RECEPTOR, SEROTONIN, 5-HT2C; RISK FACTORS; RNA EDITING; RNA, MESSENGER; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SERINE; SUICIDE; VALINE;

EID: 54249084924     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/sj.mp.4002081     Document Type: Article

References (51)

1. McGuffin P, Marusic A, Farmer A. What can psychiatric genetics offer suicidology? Crisis 2001; 22: 61-65.
2. Isometsa E, Henriksson M, Marttunen M, Heikkinen M, Aro H, Kuoppasalmi K et al. Mental disorders in young and middle aged men who commit suicide 1. BMJ 1995; 310: 1366-1367.
3. Maris RW. Suicide. Lancet 2002; 360: 319-326.
4. Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003; 4: 819-828.
5. Henriksson MM, Aro HM, Marttunen MJ, Heikkinen ME, Isometsa ET, Kuoppasalmi KI et al. Mental disorders and comorbidity in suicide. Am J Psychiatry 1993; 150: 935-940.
6. Mann JJ. The neurobiology of suicide. Nat Med 1998; 4: 25-30.
7. Asberg M, Traskman L, Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 1976; 33: 1193-1197.
8. Arango V, Underwood MD, Mann JJ. Postmortem findings in suicide victims. Implications for in vivo imaging studies. Ann NY Acad Sci 1997; 836: 269-287.
9. Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry 1999; 156: 181-189.
10. Purselle DC, Nemeroff CB. Serotonin transporter: a potential substrate in the biology of suicide. Neuropsychopharmacology 2003; 28: 613-619.
11. Joiner Jr TE, Brown JS, Wingate LR. The psychology and neurobiology of suicidal behavior. Annu Rev Psychol 2005; 56: 287-314.
12. Niswender CM, Herrick-Davis K, Dilley GE, Meltzer HY, Overholser JC, Stockmeier CA et al. RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 2001; 24: 478-491.
13. Gurevich I, Tamir H, Arango V, Dwork AJ, Mann JJ, Schmauss C. Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 2002; 34: 349-356.
14. Iwamoto K, Kato T. RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Neurosci Lett 2003; 346: 169-172.
15. Gott JM, Emeson RB. Functions and mechanisms of RNA editing. Annu Rev Genet 2000; 34: 499-531.
16. Bass BL. RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 2002; 71: 817-846.
17. Valente L, Nishikura K. ADAR gene family and A-to-I RNA editing: diverse roles in posttranscriptional gene regulation. Prog Nucleic Acid Res Mol Biol 2005; 79: 299-338.
18. Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E et al. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 1997; 387: 303-308.
19. Higuchi M, Single FN, Kohler M, Sommer B, Sprengel R, Seeburg PH. RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell 1993; 75: 1361-1370.
20. Hoopengardner B, Bhalla T, Staber C, Reenan R. Nervous system targets of RNA editing identified by comparative genomics. Science 2003; 301: 832-836.
21. Hanrahan CJ, Palladino MJ, Bonneau LJ, Reenan RA. RNA editing of a Drosophila sodium channel gene. Ann NYAcad Sci 1999; 868: 51-66.:51-66.
22. Schmauss C. Regulation of serotonin 2C receptor pre-mRNA editing by serotonin. Int Rev Neurobiol 2005; 63: 83-100.
23. Chen CX, Cho DS, Wang Q, Lai F, Carter KC, Nishikura K. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA 2000; 6: 755-767.
24. Niswender CM, Copeland SC, Herrick-Davis K, Emeson RB, Sanders-Bush E. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem 1999; 274: 9472-9478.
25. Wang Q, O'Brien PJ, Chen CX, Cho DS, Murray JM, Nishikura K. Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors. J Neurochem 2000; 74: 1290-1300.
26. Fitzgerald LW, Iyer G, Conklin DS, Krause CM, Marshall A, Patterson JP et al. Messenger RNA editing of the human serotonin 5-HT2C receptor. Neuropsychopharmacology 1999; 21: 82S-90S.
27. Herrick-Davis K, Grinde E, Niswender CM. Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction. J Neurochem 1999; 73: 1711-1717.
28. Berg KA, Cropper JD, Niswender CM, Sanders-Bush E, Emeson RB, Clarke WP. RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity. Br J Pharmacol 2001; 134: 386-392.
29. Price RD, Weiner DM, Chang MS, Sanders-Bush E. RNA editing of the human serotonin 5-HT2C receptor alters receptor-mediated activation of G13 protein. J Biol Chem 2001; 276: 44663-44668.
30. McGrew L, Price RD, Hackler E, Chang MS, Sanders-Bush E. RNA editing of the human serotonin 5-HT2C receptor disrupts transactivation of the small G-protein RhoA. Mol Pharmacol 2004; 65: 252-256.
31. Dracheva S, Davis KL, Chin B, Woo DA, Schmeidler J, Haroutunian V. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in schizophrenia. Neurobiol Dis 2006; 79: 157-173.
32. Dracheva S, Elhakem SL, Marcus SM, Siever LJ, McGurk SR, Haroutunian V. RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia. J Neurochem 2003; 87: 1402-1412.
33. Canton H, Emeson RB, Barker EL, Backstrom JR, Lu JT, Chang MS et al. Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing. Mol Pharmacol 1996; 50: 799-807.
34. Dracheva S, McGurk SR, Haroutunian V. mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics. J Neurosci Res 2005; 79: 868-878.
35. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
36. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3 (RESEARCH0034): 1-12.
37. Hedeker D, Gibbons RD. MIXREG: a computer program for mixed-effects regression analysis with autocorrelated errors. Comput Methods Programs Biomed 1996; 49: 229-252.
38. Siever LJ, Buchsbaum MS, New AS, Spiegel-Cohen J, Wei T, Hazlett EA et al. d,l-fenfluramine response in impulsive personality disorder assessed with fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology 1999; 20: 413-423.
39. Turecki G. Dissecting the suicide phenotype: the role of impulsive-aggressive behaviours. J Psychiatry Neurosci 2005; 30: 398-408.
40. Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB et al. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 1989; 46: 587-599.
41. Vitali P, Basyuk E, Le Meur E, Bertrand E, Muscatelli F, Cavaille J et al. ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D small nucleolar RNAs. J Cell Biol 2005; 169: 745-753.
42. Gurevich I, Englander MT, Adlersberg M, Siegal NB, Schmauss C. Modulation of serotonin 2C receptor editing by sustained changes in serotonergic neurotransmission. J Neurosci 2002; 22: 10529-10532.
43. Li D, He L. Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior. Mol Psychiatry 2007; 12: 47-54.
44. Arango V, Huang YY, Underwood MD, Mann JJ. Genetics of the serotonergic system in suicidal behavior. J Psychiatr Res 2003; 37: 375-386.
45. Anguelova M, Benkelfat C, Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Mol Psychiatry 2003; 8: 646-653.
46. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531.
47. Briley M, Moret C. Neurobiological mechanisms involved in antidepressant therapies. Clin Neuropharmacol 1993; 16: 387-400.
48. Pandey GN, Dwivedi Y, Ren X, Rizavi HS, Faludi G, Sarosi A et al. Regional distribution and relative abundance of serotonin(2c) receptors in human brain: effect of suicide. Neurochem Res 2006; 31: 167-176.
49. Serrats J, Mengod G, Cortes R. Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei. J Chem Neuroanat 2005; 29: 83-91.
50. Eberle-Wang K, Mikeladze Z, Uryu K, Chesselet MF. Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats. J Comp Neurol 1997; 384: 233-247.
51. Di Matteo V, Cacchio M, Di Giulio C, Esposito E. Role of serotonin(2C) receptors in the control of brain dopaminergic function. Pharmacol Biochem Behav 2002; 71: 727-734.